Literature DB >> 6958860

Concomitant adsorption and stability of some anthracycline antibiotics.

E Tomlinson, L Malspeis.   

Abstract

Using liquid scintillation counting and liquid chromatographic techniques, it has been demonstrated that the anthracycline antibiotics, doxorubicin hydrochloride, N-trifluoroacetyladriamycin-14-valerate, and N-trifluoroacetyladriamycin-14-octanoate, can be strongly absorbed to the walls of containers, depending on the nature of both the container material and the solute. It also has been shown that the esters are unstable in the chemical growth media commonly used in cell culture studies. Both the adsorption and stability effects are suggested as being factors which should be carefully considered in interpretation of the in vitro and perhaps in vivo activities of the anthracycline esters.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6958860     DOI: 10.1002/jps.2600711011

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  15 in total

Review 1.  Stability of solutions of antineoplastic agents during preparation and storage for in vitro assays. II. Assay methods, adriamycin and the other antitumour antibiotics.

Authors:  A G Bosanquet
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

2.  Aspects of the chemical stability of doxorubicin and seven other anthracyclines in acidic solution.

Authors:  J H Beijnen; G Wiese; W J Underberg
Journal:  Pharm Weekbl Sci       Date:  1985-06-21

Review 3.  Clinical pharmacokinetics of doxorubicin.

Authors:  P A Speth; Q G van Hoesel; C Haanen
Journal:  Clin Pharmacokinet       Date:  1988-07       Impact factor: 6.447

4.  Adsorption and degradation of doxorubicin from aqueous solution in polypropylene containers.

Authors:  Darren C Wu; Clyde M Ofner
Journal:  AAPS PharmSciTech       Date:  2012-12-11       Impact factor: 3.246

Review 5.  Anthracycline antitumour agents. A review of physicochemical, analytical and stability properties.

Authors:  J Bouma; J H Beijnen; A Bult; W J Underberg
Journal:  Pharm Weekbl Sci       Date:  1986-04-25

6.  Disposition of epirubicin and metabolites with repeated courses to cancer patients.

Authors:  R G Morris; D Kotasek; G Paltridge
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

7.  Doxorubicin and paclitaxel-loaded lipid-based nanoparticles overcome multidrug resistance by inhibiting P-glycoprotein and depleting ATP.

Authors:  Xiaowei Dong; Cynthia A Mattingly; Michael T Tseng; Moo J Cho; Yang Liu; Val R Adams; Russell J Mumper
Journal:  Cancer Res       Date:  2009-04-21       Impact factor: 12.701

8.  Stability of 2,5-diaziridinyl-3,6-bis(2-hydroxyethylamino)-1,4-benzoquinone (BZQ; NSC 224070) in aqueous solutions by high-performance liquid chromatography.

Authors:  A G Bosanquet; S B McLoughlin
Journal:  Invest New Drugs       Date:  1985       Impact factor: 3.850

Review 9.  A review of the stability and compatibility of antineoplastic drugs for multiple-drug infusions.

Authors:  D A Williams; J Lokich
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

10.  Stability of solutions of doxorubicin and epirubicin in plastic minibags for intravesical use after storage at -20 degrees C and thawing by microwave radiation.

Authors:  L Keusters; L M Stolk; R Umans; P Van Asten
Journal:  Pharm Weekbl Sci       Date:  1986-06-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.